诊断和治疗肝素诱导的血小板缺血的实用指南
1Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.
Hematology. American Society of Hematology. Education Program
|December 7, 2024
概括
氨酸诱导的血小板缺血 (HIT) 是对氨酸的严重免疫反应. 实践指南有助于临床医生诊断和管理HIT,重点关注风险分层,实验室测试和非肝素抗凝药,以获得更好的患者结果.
科学领域:
- 医学 医学 医学 医学 医学
- 血液学 血液学 血液学
- 临床实践 临床实践
背景情况:
- 氨酸诱导的血小板缺血 (HIT) 是对氨酸的免疫反应.
- 在住院患者中,由于频繁使用肝素和常见的血小板狭窄症,HIT 存在重大诊断和管理挑战.
- 它具有较高的发病率和死亡率风险.
研究的目的:
- 为临床医生管理疑似或确诊的HIT患者提供实际指导和工具.
- 支持基于证据的诊断和管理策略.
- 提高HIT护理的一致性和质量.
主要方法:
- 使用风险分层工具和实验室测试的逐步诊断评估.
- 选择和使用合适的非肝素抗凝剂.
- 考虑患者的特点和机构资源.
主要成果:
- 最佳的诊断包括一个结构化的方法,结合临床评估和实验室确认.
- 有效的管理需要仔细选择抗凝剂,以平衡血栓和出血风险.
- 工具的实施可以增强一致,高质量和成本效益的HIT护理.
结论:
- 通过支持性工具和基于证据的策略,可以实现HIT的实际管理.
- 对复杂的HIT患者来说,对诊断和抗凝药的系统方法至关重要.
- 在整个卫生系统中实施HIT护理工具可以标准化和改善患者的治疗结果.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
616
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
616
Disorders of Hemostasis
707
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
707
Introduction to Hemostasis
5.6K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.6K
Esophageal Varices-II: Clinical Features and Management
46
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
46
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
468
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
468


